JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

1/11/23 1:00:00 PM ET

$AEZS

$AIM

$AMAO

$AREC

Biotechnology: Pharmaceutical Preparations

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Get the next $AEZS alert in real time by email

- Live video webcast presentations with participating companies -

FRENCHTOWN, NJ / ACCESSWIRE / January 11, 2023 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2023 Companies to Watch Event, January 17-19, 2023. As part of the virtual event, participating companies will provide a corporate presentation.

The schedule for the event is as follows:

Tuesday, January 17, 2023

9:00 AM ET: Moleculin Biotech, Inc. (NASDAQ:MBRX) - WEBCAST
10:00 AM ET: Xenetic Biosciences, Inc. (NASDAQ:XBIO) - WEBCAST
11:00 AM ET: Outlook Therapeutics, Inc. (NASDAQ:OTLK) - WEBCAST
1:00 PM ET: Vallon Pharmaceuticals, Inc. (NASDAQ:VLON)/GRI Bio (Private) - WEBCAST
2:00 PM ET: Novan, Inc. (NASDAQ:NOVN) - WEBCAST
3:00 PM ET: Palisade Bio, Inc. (NASDAQ:PALI) - WEBCAST
4:00 PM ET: American Resources Corporation (NASDAQ:AREC) - WEBCAST

Wednesday, January 18, 2023

10:00 AM ET: CNS Pharmaceuticals Inc. (NASDAQ:CNSP) - WEBCAST
11:00 AM ET:AIM ImmunoTech Inc. (NYSE:AIM) - WEBCAST
1:00 PM ET: Panavance Therapeutics Inc. (Private) - WEBCAST
2:00 PM ET: ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) -WEBCAST
3:00 PM ET: Ceapro, Inc. (TSXV:CZO, OTCQX:CRPOF) - WEBCAST
4:00 PM ET: iTolerance, Inc. (Private) - WEBCAST

Thursday, January 19, 2023

10:00 AM ET: Adolore Biotherapeutics, Inc. (Private) - WEBCAST
11:00 AM ET: Cyclo Therapeutics, Inc. (NASDAQ:CYTH) - WEBCAST
1:00 PM ET: enVVeno Medical Corporation (NASDAQ:NVNO) - WEBCAST
2:00 PM ET: American Acquisition Opportunity Inc. (NASDAQ:AMAO) - WEBCAST
3:00 PM ET: Aeterna Zentaris Inc. (NASDAQ:AEZS, TSX:AEZS) - WEBCAST
4:00 PM ET: SurgePays, Inc. (NASDAQ:SURG) - WEBCAST

About JTC Team

JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.

Contact:

Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
[email protected]

SOURCE: JTC Team, LLC

View source version on accesswire.com:
https://www.accesswire.com/734876/JTC-Team-to-Host-the-Virtual-Investor-2023-Companies-to-Watch-Event-on-January-17th-18th-and-19th

Get the next $AEZS alert in real time by email

Company	Date	Price Target	Rating	Analyst
American Resources Corporation $AREC	11/26/2025	$7.00	Buy	Maxim Group
American Resources Corporation $AREC	10/20/2025		Outperform	William Blair
American Resources Corporation $AREC	9/15/2025	$6.00	Buy	D. Boral Capital
Outlook Therapeutics Inc. $OTLK	8/29/2025		Buy → Neutral	H.C. Wainwright
Outlook Therapeutics Inc. $OTLK	8/28/2025		Buy → Neutral	Guggenheim
Moleculin Biotech Inc. $MBRX	6/9/2025	$4.00	Buy	H.C. Wainwright
Moleculin Biotech Inc. $MBRX	2/12/2025		Buy → Hold	Maxim Group
Outlook Therapeutics Inc. $OTLK	12/2/2024		Buy → Neutral	Chardan Capital Markets

JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$AEZS
$AIM
$AMAO
$AREC

$AEZS
$AIM
$AMAO
$AREC
Insider Purchases

Director May David Allen bought $61,647 worth of Shares of Common Stock (38,422 units at $1.60), increasing direct ownership by 32% to 158,116 units (SEC Form 4)

Large owner Golden Properties Ltd. decreased direct ownership by 7% to 12,389,960 units (SEC Form 4)

Large owner Golden Properties Ltd. decreased direct ownership by 7% to 13,389,960 units (SEC Form 4)

$AEZS
$AIM
$AMAO
$AREC
Analyst Ratings

Maxim Group initiated coverage on American Resources Corp. with a new price target

William Blair initiated coverage on American Resources Corp.

D. Boral Capital resumed coverage on American Resources Corp. with a new price target

$AEZS
$AIM
$AMAO
$AREC
SEC Filings

enVVeno Medical Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

SEC Form DEFA14A filed by Xenetic Biosciences Inc.

Xenetic Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

$AEZS
$AIM
$AMAO
$AREC
Press Releases

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds

Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal "MIRACLE" Phase 3 AML Trial on Pace for Q1 2026

$AEZS
$AIM
$AMAO
$AREC
Insider Trading

Director Duhay Francis sold $1,742 worth of shares (4,900 units at $0.36), decreasing direct ownership by 5% to 92,544 units (SEC Form 4)

Director May David Allen bought $61,647 worth of Shares of Common Stock (38,422 units at $1.60), increasing direct ownership by 32% to 158,116 units (SEC Form 4)

SEC Form 4 filed by Director Keyes Jeffry R.

JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $AEZS$AIM$AMAO$AREC

$AEZS$AIM$AMAO$AREC Insider Purchases

Director May David Allen bought $61,647 worth of Shares of Common Stock (38,422 units at $1.60), increasing direct ownership by 32% to 158,116 units (SEC Form 4)

Large owner Golden Properties Ltd. decreased direct ownership by 7% to 12,389,960 units (SEC Form 4)

Large owner Golden Properties Ltd. decreased direct ownership by 7% to 13,389,960 units (SEC Form 4)

$AEZS$AIM$AMAO$AREC Analyst Ratings

Maxim Group initiated coverage on American Resources Corp. with a new price target

William Blair initiated coverage on American Resources Corp.

D. Boral Capital resumed coverage on American Resources Corp. with a new price target

$AEZS$AIM$AMAO$AREC SEC Filings

enVVeno Medical Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

SEC Form DEFA14A filed by Xenetic Biosciences Inc.

Xenetic Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

$AEZS$AIM$AMAO$AREC Press Releases

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds

Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal "MIRACLE" Phase 3 AML Trial on Pace for Q1 2026

$AEZS$AIM$AMAO$AREC Insider Trading

Director Duhay Francis sold $1,742 worth of shares (4,900 units at $0.36), decreasing direct ownership by 5% to 92,544 units (SEC Form 4)

Director May David Allen bought $61,647 worth of Shares of Common Stock (38,422 units at $1.60), increasing direct ownership by 32% to 158,116 units (SEC Form 4)

SEC Form 4 filed by Director Keyes Jeffry R.

Recent Analyst Ratings for
$AEZS
$AIM
$AMAO
$AREC

$AEZS
$AIM
$AMAO
$AREC
Insider Purchases

$AEZS
$AIM
$AMAO
$AREC
Analyst Ratings

$AEZS
$AIM
$AMAO
$AREC
SEC Filings

$AEZS
$AIM
$AMAO
$AREC
Press Releases

$AEZS
$AIM
$AMAO
$AREC
Insider Trading